Marina Berenguer
Editor

2014

Chronic infection with the hepatitis C virus is at epidemic proportions and is currently the leading indication for liver transplantation, not only in the setting of liver insufficiency but particularly due to the significant increase of hepatocellular carcinoma arising on HCV-cirrhotic livers. Unfortunately, despite advances in antiviral therapies, many patients remain infected at the time of transplantation, resulting in the vast majority in graft reinfection.